131 completed. 131 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 131 | Completed 131 |
Follow Fibrosis: new trials by email Literature Review of Fibrosis trials Research Report on Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Period of Open Excisional Hemorrhoidectomy (The Emor Study) Gel containing a Propionibacterium extract, Hyaluronic acid and silver sulfadiazine - Anus Diseases, Gastrointestinal Diseases | Phase 4 | Completed | University of Cagliari | 114 | 2025-03-04 | 2025-07-02 |
| A Trial for Comparing Rifaximin, Probiotic and L-ornithine- L Aspartate With Lactulose in Overt Hepatic Encephalopathy. Probiotic plus lactulose, Rifaximin plus lactulose, L-ornithine-L-aspartate plus latulose - Overt Hepatic Encephalopathy | Phase 4 | Completed | Qurratul Ain Jamil | 252 | 2024-12-02 | 2025-06-25 |
| A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients Mirabegron 100 mg, Mirabegron 50mg, mirabegron 25 mg - Cirrhosis, Asthma | Phase 4 | Completed | Kafrelsheikh University | 78 | 2024-07-01 | 2026-04-16 |
| Dose Optimization of Sitagliptin and Duloxetine in Diabetic Cirrhosis Sitagliptin (Januvia), Sitagliptin (JANUVIA®), Duloxetine (60 mg) once daily - Liver Cirrhosis With Diabetes | Phase 4 | Completed | Kafrelsheikh University | 64 | 2024-07-01 | 2026-02-27 |
| Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein Thrombosis Warfarin 3 mg, Warfarin 2 mg - Liver Cirrhosis, Portal Vein Thrombosis | Phase 4 | Completed | Kafrelsheikh University | 21 | 2024-03-15 | 2026-05-06 |
| Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis Simvastatin 15 mg, Simvastatin 5 mg - Liver Cirrhosis, Portal Hypertension Related to Cirrhosis | Phase 4 | Completed | Kafrelsheikh University | 22 | 2024-03-15 | 2026-03-11 |
| Clinical Application of Simcyp-Guided Doses of Antihypertensive Drugs in Cirrhotic Patients Nebivolol 5 mg, Carvedilol 12.5 mg, Nebivolol 2.5 mg - Liver Cirrhosis, Arterial Hypertension | Phase 4 | Completed | Kafrelsheikh University | 40 | 2024-03-01 | 2026-02-09 |
| Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC Elecsys® GAAD - Liver Cirrhosis, Hepatocellular Carcinoma | Phase 4 | Completed | Manchester University NHS Foundation Trust | 657 | 2024-01-08 | 2026-10-09 |
| Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis Branched-chain Amino Acid, Placebo - Muscle Cramp, Cirrhosis | Phase 4 | Completed | Mahidol University | 48 | 2023-04-01 | 2024-02-09 |
| Effect of Intravesical B.C.G and Gemcitabine on Semen Analysis and Testicular Volume in NMIBC Bacillus Calmette Guerin, Gemcitabine HCL (Gemzar) - Urothelial Carcinoma Bladder, Sperm Count, Low | Phase 4 | Completed | Assiut University | 86 | 2023-04-01 | 2026-10-29 |
| Efficacy of Different Doses of Bezafibrate in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cholangitis UDCA 13-15 mg/kg/day, UDCA 13-15 mg/kg/day + Bezafibrate 400 mg/day, UDCA 13-15 mg/kg/day + Bezafibrate 800 mg/day - Primary Biliary Cholangitis (PBC) | Phase 4 | Completed | Instituto de Biotecnologia de Misiones | 60 | 2023-03-01 | 2026-11-10 |
| Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome L-ornithine L-aspartate - Cirrhosis | Phase 4 | Completed | Medical University of Graz | 52 | 2023-02-06 | 2026-10-09 |
| Microneedling vs. 5-Fluorouracil or Steroid Injections for Hypertrophic Scars and Keloids Microneedling with 5-Fluorouracil, Intralesional 5-fluorouracil, Intralesional Triamcinolone Acetonide - Keloid Scars, Hypertrophic Scar | Phase 4 | Completed | Alexandria University | 60 | 2023-01-12 | 2026-07-22 |
| Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease Denosumab, Alendronate Sodium - Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal | Phase 4 | Completed | Aristotle University Of Thessaloniki | 72 | 2022-12-23 | 2026-07-23 |
| Efficacy and Safety of Intravenous Vitamin K1 in Management of Acute Variceal Bleeding Vitamin K1 - Variceal Bleeding | Phase 4 | Completed | Zagazig University | 66 | 2022-10-03 | 2025-02-21 |
| Explore the Short- and Mid-term Effects of Fespixon in Scar Cosmesis Following Cervical or Abdominal Surgery Fespixon cream, Placebo Cream - Scar | Phase 4 | Completed | National Defense Medical Center, Taiwan | 46 | 2022-01-05 | 2022-12-28 |
| The Effect of Intralesian Injection of Umbilical Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide on Type 1:3 Collagen Ratio and Interleukin-10 Levels in Keloid: A Randomised Controlled Trial umbilical cord-derived mesenchymal stem cells (UC-MSC), umbilical cord-derived mesenchymal stem cells conditioned medium (UC-CM), Triamcinolone Acetonide (TA) - Keloid, Stem Cell | Phase 4 | Completed | Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | 24 | 2021-10-01 | 2023-07-11 |
| Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial umbilical cord-derived mesenchymal stem cells (UC-MSC), umbilical cord-derived mesenchymal stem cells conditioned medium (UC-CM), Triamcinolone Acetonide (TA) - Keloid, Stem Cell | Phase 4 | Completed | Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | 24 | 2021-10-01 | 2023-06-07 |
| Dupilumab in the Treatment of Keloids Dupilumab, Placebo - Keloid | Phase 4 | Completed | Icahn School of Medicine at Mount Sinai | 44 | 2021-05-25 | 2025-07-04 |
| Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy Sulperazon, Teicoplanin, Meropenem Injection - Cholangitis, Secondary Biliary, Treatment Compliance | Phase 4 | Completed | Tongji Hospital | 160 | 2021-05-01 | 2022-04-11 |
Showing 20 of 131. Sign in to see all of them.
Liver Cirrhosis (33) · Cicatrix (11) · Hepatic Encephalopathy (11) · Hypertension, Portal (10) · Keloid (10) · Hepatitis C (8) · Ascites (7) · Cicatrix, Hypertrophic (6) · Gastrointestinal Hemorrhage (5) · Liver Cirrhosis, Biliary (5) · Pulmonary Fibrosis (5) · Tissue Adhesions (5) · Brain Diseases (4) · Hepatitis C, Chronic (4)
Pathologic Processes (131) · Pathological Conditions, Signs and Symptoms (131) · Digestive System Diseases (72) · Liver Diseases (64) · Infections (20) · Cicatrix (17) · Virus Diseases (17) · Hepatitis (16) · Blood-Borne Infections (15) · Communicable Diseases (15) · Hepatitis, Viral, Human (15) · Metabolic Diseases (15) · Nervous System Diseases (15) · Nutritional and Metabolic Diseases (15)
Ribavirin (7) · Albumins (5) · Rifaximin (5) · Sodium Chloride (5) · Spironolactone (5) · ornithylaspartate (5) · Warfarin (4) · entecavir (4) · Furosemide (3) · Lactulose (3) · Nadroparin (3) · Sofosbuvir (3) · Terlipressin (3) · Therapeutics (3) · peginterferon alfa-2a (3)
Hospital Clinic of Barcelona (5) · Kafrelsheikh University (5) · Beijing Friendship Hospital (3) · Mahidol University (3) · Medical University of Vienna (3) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3) · Bayer (2) · Beth Israel Deaconess Medical Center (2) · Cairo University (2) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (2) · GlaxoSmithKline (2) · Hospital Universitari Vall d'Hebron Research Institute (2) · Icahn School of Medicine at Mount Sinai (2) · Korea University (2) · Qilu Hospital of Shandong University (2)
United States (29) · China (16) · Egypt (12) · Spain (11) · South Korea (8) · Italy (7) · Austria (6) · United Kingdom (6) · Thailand (5) · Canada (4) · Germany (4) · India (4) · Mexico (4) · Taiwan (4) · Belgium (3)
Arnulf Ferlitsch, MD (3) · Hong You, Doctor (3) · Aya Emad Fouda, MSc in Clinical Pharmacy (2) · Noha Mahmoud El-khodary, PhD (2) · Yanjing Gao, PhD.MD (2) · Adriano M Pellicelli, MD (1) · Ahmed A Ali, PhD (1) · Ahmed A. Gomaa, MD (1) · Ahmed M Eltaher, professor (1) · Alexander M Milstein, MD (1) · Amira Dieb, MD (1) · Andrew Scanga, MD (1)
PMID 37467180, PMID 19570764, PMID 39373164, PMID 10347109, PMID 10403745, PMID 11208726, PMID 11588440, PMID 11772973, PMID 12500513, PMID 12699951, PMID 12806613, PMID 12873814, PMID 12924658, PMID 12963433, PMID 15222044, PMID 16134766, PMID 16206505, PMID 16460491, PMID 17234504, PMID 17387740, PMID 17484872, PMID 18251131, PMID 18410283, PMID 18492024, PMID 18547224, PMID 19628656, PMID 20109575, PMID 20163377, PMID 20981308, PMID 21563202, PMID 22095893, PMID 22801062, PMID 22825550, PMID 22835465, PMID 23542334, PMID 23872605, PMID 24151551, PMID 24509969, PMID 24840288, PMID 24942957, PMID 24997638, PMID 25546176, PMID 25557952, PMID 26191473, PMID 26744140, PMID 26890629, PMID 27121784, PMID 27467714, PMID 27614675, PMID 27775818
2008 (4), 2014 (1), 2016 (1), R01DK087913 (1), U01AI115714 (1)